Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

According to WSJ, Bio-Rad Laboratories (BIO) in Talks to Combine With Qiagen (QGEN)

  • October 10, 2022


StockQiagen N.V.SymbolQGEN
Date Announced10/10/2022Source Wall Street Journal
TypeNews Report

Bio-Rad Laboratories Inc. (BIO) is in talks to combine with fellow life-sciences company Qiagen (QGEN) in a deal that would be worth more than $10 billion, according to people familiar with the matter.

Disclaimer: Our intent with this section of the website is to present potential deals that appear to be in the pipeline. These potential deals are ones where i) the company has indicated that it is "seeking strategic alternatives", ii) there has been an unsolicited bid for a company as mentioned in a press release by the company or iii) news about the deal has been published by a leading news organization like The Wall Street Journal, The New York Times, Bloomberg, Financial Times, The Washington Post, Reuters and The Associated Press. As best as possible we will try to avoid baseless rumors. There is a high probability that many of these potential deals may not materialize and if they do, the terms of the deal may be different from what was initially reported. Please do your own due diligence before buying or selling any securities mentioned on this website. We do not warrant the completeness or accuracy of the content or data provided.